Diagnostics – Talk Bio

Actionable Insights Powered by AI

ASCO25 Primer: Navigating Cancer R&D Amid Regulatory Uncertainty

3 weeks ago talkbio0Tagged ASCO25, Cancer Research, Changing, Diagnostics, expert, Immunotherapy, Neoplasms, perspectives, Policy, Precision Medicine, regulatory uncertainty

ASCO25; cancer research; oncology; regulatory uncertainty; immunotherapy; precision medicine; diagnostics; expert perspectives; policy changes

Eisai Anticipates Growth Acceleration for Alzheimer’s Drug Leqembi Despite Slow Initial Uptake

4 months ago talkbio0Tagged Adoption, Alzheimer 's disease, Diagnostics, dosing, Eisai, expansion, Growth, Leqembi, Maintenance, Phase, Sales - occupational activity

Leqembi, Alzheimer’s disease, Eisai, expansion phase, sales growth, diagnostics, maintenance dosing, patient adoption

Medtronic’s PillCam Genius SB Completes First Patient Procedure for GI Diagnostics

6 months ago talkbio0Tagged antimony, Capsule Endoscopy, Diagnostics, gastroenterology (field), Ingestion, Medtronic, PillCam Genius, Telemedicine

Medtronic, PillCam Genius SB, Capsule Endoscopy, GI Diagnostics, At-Home Ingestion, Telehealth

Philips and AWS Strengthen Strategic AI Partnership, Expanding Cloud-Enabled Diagnostics to Europe

6 months ago talkbio0Tagged Alagille Syndrome, Diagnostics, European (ethnic group), expansion, Generative AI, healthcare innovation, Integrated Diagnostics Portfolio, Philips, Strategic AI Collaboration

Philips, AWS, Strategic AI Collaboration, Cloud-Enabled Diagnostics, European Expansion, Healthcare Innovation, Integrated Diagnostics Portfolio, Generative AI Applications

Cradle Bio Secures $73M Series B Funding to Revolutionize AI-Driven Protein Engineering

6 months ago talkbio0Tagged AI-powered protein engineering, Cradle, Diagnostics, Series B

AI-powered protein engineering, Cradle Bio, Series B funding, pharmaceuticals, diagnostics, biotech startup

QIAGEN and AstraZeneca Enhance Partnership to Develop Companion Diagnostics for Chronic Diseases

9 months ago talkbio0Tagged AstraZeneca, Chronic disease, Diagnostics, genotyping assay, Pet Animal, Precision Medicine, QIAGEN, QIAstat-Dx

QIAGEN, AstraZeneca, companion diagnostics, chronic diseases, precision medicine, QIAstat-Dx, genotyping assay

FDA Approves Illumina’s TruSight Oncology Comprehensive Test for Pan-Cancer Companion Diagnostics

9 months ago talkbio0Tagged Approved, cellular targeting, Comprehensive, Diagnostics, Gene Fusion, Illumina, Neoplasms, NTRK, pan-cancer, Pet Animal, Precision - temporal, RET protein, human, TruSight Oncology, United States Food and Drug Administration

FDA approval, Illumina, TruSight Oncology Comprehensive, pan-cancer, companion diagnostics, NTRK gene fusions, RET fusion-positive NSCLC, targeted therapies, precision oncology.

Cleveland Diagnostics Launches Second Annual Prostate Cancer Awareness Campaign

9 months ago talkbio0Tagged Awareness, campaign, Cleveland, Detection, Diagnostics, IsoPSA test, Malignant neoplasm of prostate

prostate cancer, IsoPSA test, Cleveland Diagnostics, awareness campaign, early detection

PreciseDx Secures $20.7 Million in Series B Funding to Enhance AI-Driven Breast Cancer Risk Assessments

10 months ago talkbio0Tagged AI-Powered Cancer, Diagnostics, Malignant neoplasm of breast, PreciseDx, Precision Medicine, Series B

PreciseDx, AI-Powered Cancer Risk Assessments, Breast Cancer Diagnostics, Series B Funding, Precision Medicine

Illumina’s Board Approves Spin-Off of Grail, a Cancer Diagnostics Firm

1 year ago talkbio0Tagged Diagnostics, DNA Sequence, Grail, Illumina, Malignant Neoplasms

Illumina, Grail, spin-off, cancer diagnostics, DNA sequencing